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ABSTRACT
Objective: To determine antiretroviral drug adherence levels of HIV/AIDS in adult 
patients.  
Design: A cross sectional study. 
Setting: Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya. 
Subjects: Three hundred and eighty four HIV/AIDS adult patients who attended 
HIV/AIDS clinic in MTRH for antiretroviral treatment and had been on treatment 
for at least three months as confirmed by clinicians. 
Results: Three hundred and eighty four respondents participated in this research; 
two third of whom were females (68%) and a third were males (32%). Fifty two per 
cent of these had attained secondary or post secondary education. The mean age was 
36.1±8.5, years and ranged 18-63 years. While 93.5% of the participants adhered to clinic 
appointments, only 43.2% adhered to taking the drugs as per time schedule.  
Conclusion: Adherence to time of taking medications was low and could result in 
reduced efficacy.  
INTRODUCTION
In Kenya, AIDS is a rapidly growing public health 
problem. In less than a decade, AIDS has evolved 
from a fulminant, rapidly fatal illness into a chronic 
disease. Already, more than 2 million people are 
estimated to have been infected in Kenya as from 
1985 when the first case of AIDS was recognised (1). 
In Moi Teaching and Referral Hospital (MTRH), HIV/
AIDS patients receive free ARVs through Academic 
Model for Prevention and Treatment of HIV/AIDS 
(AMPATH) programme.
 Antiretroviral medications are effective but 
are complex and require near perfect adherence 
to the prescribed regimen to achieve and maintain 
their efficacy. In order to be effective, treatment of 
HIV/AIDS with antiretroviral requires 100% rate of 
adherence   (2, 3). Several studies have demonstrated 
that, the consequences of missed doses or poor 
adherence to HAART is critical, with evidence of an 
increasing viral load after only two days of default 
followed by development of mutant viral strains 
(4,5). As blood drug levels fall below a critical point, 
the regimens inhibitory effect on viral replication 
decreases and this allows for increases in viral load. 
Studies have shown that, among the patients suffering 
from HIV/AIDS, only about one third take their 
medications as prescribed while the rest do not (6).
 The aim of this study was to determine adherence 
levels among HIV/AIDS adult patients using timing of 
medications and keeping of clinic appointments for drug 
refills as key indicators of adherence. It also determined 
the association between the two indicators. 
MATERIALS AND METHODS
Study area and design:This study was conducted at 
Moi Teaching and Referral Hospital (MTRH), Eldoret, 
Kenya from May to July 2005. It was a cross-sectional 
study and it examined demographic and other 
characteristics of the respondents and antiretroviral 
drug adherence levels.
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Study population: The study population consisted of 
HIV/AIDS adult patients on ARVs and attending 
AMPATH HIV clinic at MTRH. Expectant mothers 
were excluded from the study as they were on a 
different programme.
Data collection: Data collection was done after receiving 
approval letter from Institutional Research and 
Ethics Committee (IREC) from Moi University/Moi 
Teaching and Referral Hospital (MTRH). Three 
hundred and eighty four adult patients (both males 
and females of 18 years and above) were interviewed 
after the purpose of the study was explained to them 
and were assured of confidentiality.  The researchers 
worked in association with the clinicians in the HIV/
AIDS clinic. Clinicians identified patients who had 
been on ARV treatment for at least three months. 
Once ARV drugs had been prescribed, the patient 
moved to the pharmacy to collect them. It was at 
this point that the researchers, by use of interview-
administered questionnaires interviewed the patients. 
The interview was continued on consecutive patients 
until the determined sample of 384 was attained, 
The questionnaire sought demographic data and 
ARV drug adherence levels of the patients based on 
timing of taking drugs. Information on adherence 
to clinic appointments was obtained from hospital 
health records.
Data analysis: Data generated from the questionnaire 
were  analysed using statistical package for social 
scientist (SSPS) version 10.0 for  frequencies, cross-
tabulation and chi-square at the significant level of 
p>0.05.
RESULTS
Demographic and other characteristic of respondents: 
Majority of the respondents on ARVs were females 
261 (68%). More than half of the respondents 200 (52%) 
had attained secondary or post secondary education. 
The respondents were aged between 18-63 years 
(mean age 36.1 ± 8.5 years). Half of the participants 
198 (51.6%) were between the age groups of 26-35 
years. Majority of the respondents were married 272 
(70.8%). One hundred and four (84.6%) of the males 
were married as compared to 168 (64.4%) of females. 
More than half 214 (55.7%) of the participants lived 
outside Eldoret Municipality. However, both males 
and females had comparable place of residence 
(p=0.569) and education levels (p=0.921). The age 
distribution, marital status, employment status, time 
of working between the two sexes were significantly 
different (p=0.000) respectively.
Antiretroviral drug adherence levels: The overall 
adherence level based on timing of medications 
was 43.2% (45.5% for males and 42.1% for females 
respectively). On keeping of clinic appointments, 
the overall adherence level was 93.5% (95.1% and 
92.7% for males and females respectively - Table 1). 
Overall, there was no association between adherence 
based on timing of taking drugs and adherence 
based on keeping of clinic appointments among 
all the respondents (X2 = 0.2480, P = 0.618). The 
same result was true for males and females (Table 
2). Fewer males failed to keep clinic appointments 
hence the interpretations of the Chi-square in Table 
2 is unreliable. However, Cochran and Daniel (7,8) 
suggested that when n ≥ 40, an expected cell frequency 
as small as 1 can be tolerated.
Table 1
Drug adherence levels for all respondents based on timing of taking drugs and keeping of clinic appointments
Kept clinic Took drugs on time scheduled   Total X2 P-value
appointment  No.   (%)  No.   (%)  No.   (%)
Yes  154   40.1 205   53.4 359   93.5
No  12    3.1 13     3.4 25     6.5 0.2480 0.618
Total  166   43.2 218   56.3 384    100
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DISCUSSION
The measurement of medication adherence is a 
difficult endeavor both in clinical care and research 
settings. Quantifying the levels and types of 
medication adherence involving patient care has been 
the focus of many studies resulting in the identification 
of multiple direct and indirect measures (9, 10). It 
is difficult to measure adherence in the outpatient 
setting with absolute precision and accuracy (11). 
While there may be no gold standard with which to 
measure adherence, there are several strategies that 
have been used to assess adherence which includes, 
clinician assessment, pill counts, prescription refills, 
biological assays, Medication Event Monitoring 
System (MEMS), Directly Observed Therapy (DOT) 
and Self report (SR)(12-15). Most studies of adherence 
use one or more of these tools. 
 In the current study, a combination of self reports 
by patients on timing of taking ARV drugs and 
information from hospital health records on keeping 
of clinic appointments for prescription refills by the 
same patients was used as key indicators. Previous 
studies have found self-reports to be a useful tool in 
measuring adherence and it is very reliable when 
patients report on non-adherence (10). However 
several studies suggest that self-reports tend to 
overestimate actual adherence (10, 16).
 The findings of this study established that the 
overall antiretroviral drug adherence level of all the 
respondents was 43.2% and 93.5% based on keeping to 
scheduled timing of medication and keeping scheduled 
clinic appointments respectively (Table 1). The adherence 
levels of the respondents based on keeping to timing 
of medication were very low. However, it was difficult 
to establish if the patients took drugs at a later time or 
failed completely. This closely corresponds to the study 
carried on Zidovudine adherence among individuals 
with HIV infection, which gave an adherence level 
of 42% (17).  Timing of doses of ARVs is very critical 
because, as drug levels fall below a critical point, the 
regimens inhibiting effect on viral replication may lessen 
allowing for increase in the viral load (4, 5).
 Adherence levels based on timing of taking 
drugs for males, 56(45.5%) was slightly higher than 
that for females, 110(42.1%), (Table 2). This could be 
explained by the fact that women were very busy with 
household responsibilities that could have disrupted 
their adherence to timing of taking drugs. This could 
be related to the fact that more women than men were 
divorced, widowed or separated. Studies have shown 
that patients with supportive friends and families 
tend to adhere to ARVs better than those without 
such supports (18, 20).
 Though adherence level of 93.5% for clinic 
appointments as shown in Table 1, was close to the 
ideal expectations, it is important to note that patients 
may take home adequate amount of drugs but may 
not take them appropriately due to complexities of 
prescribed regimens and difficulties in understanding 
instructions. This high level of adherence indicated 
that the respondents tried hard to adhere to the 
scheduled clinic visits for prescription refills possibly 
because they received free ARVs. Studies in South 
Africa indicated that indigent patients recruited 
from the greater Cape Town area, receiving free 
therapy on clinic trial took 93.5% of their medication 
as measured by clinic based pill count (21). A study 
in Senegal reported 87.9% adherence among poor 
patients receiving free ARVs (22).
 In this current study, males were more adherent 
to clinic appointments (95.1%) than females 92.7%. 
Again as for the keeping of treatment time, the 
demanding domestic responsibilities of women could 
have contributed to lower adherence. This confirmed 
the role of patient characteristics and attitudes 
regarding HAART adherence, and demonstrated 
that men were more adherent than women (23).
 This study established that there was no 
association between timing of medications and keeping 
of clinic appointments among the respondents. Other 
studies have shown that patients may keep to clinic 
Table 2
Drug adherence levels for males and females based on timing of taking medications and keeping of clinic 
appointments
Kept clinic    Took drugs on time
appointment      Males (n=123)            Females (n=261)
   Yes     No   Total X2 P-value   Yes    No   Total X2 P -value 
 No. (%) No. (%) No.  (%)   No. (%) No. (%) No. (%)
Yes 53 43.1 64 52.1 117 95.1   101 38.7 141 54.0 242 92.7
No   3 2.4  3 2.4   6 4.9 0.051* 0.822*   9 3.9  10 3.9  19 7.3  0.299  0.632
Total  56 45.5 67 54.7 123 100   110 42.1 151 57.9  261 100
Note*: Two cells have expected cell frequencies less than 5
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appointments and take home adequate prescribed 
doses but may not take them at appropriate times 
(10,24). Achieving 100% adherence for any treatment is 
therefore not realistic. This is particularly difficult for 
patients living in rural areas where routine activities 
are not time bound and therefore of little help as 
reminders to the patients to take their prescribed 
drugs. 
 In conclusion, the overall adherence levels 
based on timing of taking drugs was very poor 
compared to keeping of clinic appointments among 
all respondents and between males and females. 
There was no significant relationship between timing 
of medications and keeping of clinic appointments. 
It was recommended that there was need to 
educate patients on importance of adhering to drug 
administration. Similarly, it was important to establish 
the underlying cause of disparity between refills and 
time of taking drugs.
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